Rheumatology Product Review - Apremilast in psoriatic arthritis

This review is a summary of evidence in support of apremilast’s (Otezla®) use in patients with psoriatic arthritis.

Independent expert commentary provided by Associate Professor Peter Nash.

Please login below to download this issue (PDF)

Subscribe